TNFalfa Blocking Treatment of Spondylarthropathies
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to establish a Danish cohort of spondylarthropathy (SpA) patients
who are being treated with TNFalfa blockers. By following the TNFalfa blocking treated
patients the researchers want to identify better biomarkers for disease activity and disease
progression. In addition, the researchers want to identify predictors for disease
progression.